Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 6,244 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Weekly Assessment Clear all

Conditions: Recurrent Glioma, High-grade Meningioma, Brain Metastasis
Interventions: Panobinostat, Stereotactic body radiation therapy, Quality-of-life assessment, Stereotactic radiosurgery; Drug · Radiation · Procedure
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Domestic Violence, Post Traumatic Stress Disorder
Interventions: SAH, TAU; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Defective; Circulation
Interventions: Erchonia HP Scanner (HPS); Device
Lead sponsor: Erchonia Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Attention-deficit Hyperactivity Disorder (ADHD)
Interventions: NFC-1; Drug
Lead sponsor: Aevi Genomic Medicine, LLC, a Cerecor company; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Parkinson Disease
Interventions: Physical Activity Coaching; Behavioral
Lead sponsor: Teachers College, Columbia University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Risk Factor, Menopause Related Conditions, Neuromuscular Function, Aerobic Capacity, Inflammation
Interventions: Resistance Exercise, Aerobic Exercise; Behavioral
Lead sponsor: Oklahoma State University; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Stillwater, Oklahoma

Conditions: Diabetes Mellitus, Type 2
Interventions: BT-001, Control App; Behavioral · Other
Lead sponsor: Better Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • New Orleans, Louisiana • Durham, North Carolina

Conditions: Stress, Anxiety, Depression
Interventions: Non-Deceptive Placebo; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Colorectal Cancer, Diet Habit
Interventions: Med, WL; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years to 75 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pelvic Pain
Interventions: Yoga Therapy; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older · Female only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes Mellitus, Type 2
Interventions: digoxin plus albiglutide; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Austin, Texas

Conditions: High Intensity Interval Training, Overweight and Obesity, Metabolic Disease, Cognition
Interventions: HIIT Exercise Intervention, Stretching Intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 12 Years to 16 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV Infections
Interventions: Family-Based Risk Reduction Intervention; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 15 Years to 19 Years · Female only
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 2
States / cities: Chicago, Illinois • New York, New York

Conditions: Survivorship, Cancer, Psychological Well-Being
Interventions: an empirically supported protocol, further refined with evidence-based strategies, Health education; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Phenylketonuria
Interventions: Pegvaliase, Methotrexate; Biological · Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 12
States / cities: Los Angeles, California • Aurora, Colorado • Tampa, Florida + 9 more

Conditions: Fatigue, Nausea and Vomiting, Pain, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage I-IVB Colon Cancer, Stage I-IVB Rectal Cancer
Interventions: Yoga therapy, questionnaire administration, quality-of-life assessment, laboratory biomarker analysis, assessment of therapy complications, management of therapy complications, educational intervention; Procedure · Other
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pediatric Obesity
Interventions: DRIVE Program; Behavioral
Lead sponsor: Georgia State University; Other
Eligibility: 2 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Atlanta, Georgia • Baton Rouge, Louisiana

Conditions: Obesity or Overweight, Type 2 Diabetes Mellitus
Interventions: Placebo, Enicepatide; Combination Product
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 45
States / cities: Guntersville, Alabama • Tucson, Arizona • Irvine, California + 41 more

Conditions: Cardiac Rehabilitation
Interventions: Tailored cardiac rehabilitation, Referral to an external cardiac rehabilitation program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: photobiomodulation, Sham treatment, Physiotherapy; Device · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Prostatic Neoplasm
Interventions: EZN-4176; Drug
Lead sponsor: Enzon Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Splenic Marginal Zone Lymphoma
Interventions: Ipilimumab, SD-101, Radiation therapy; Biological · Drug · Radiation
Lead sponsor: Robert Lowsky; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Gestational Diabetes Mellitus
Interventions: Hola Bebe; Behavioral
Lead sponsor: Environment and Health Group, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Cambridge, Massachusetts • Jamaica Plain, Massachusetts • Lynn, Massachusetts

Conditions: Migraine Disorders, Post-Traumatic Headache
Interventions: Osteopathic Manipulation; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: La Jolla, California

Search by objective public record fields.

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

Evaluation of a Trauma-Informed Partner Violence Intervention Program

Study of Low Level Laser Light Therapy to Improve Blood Circulation in People With Chronic Heel Pain

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder

Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)

The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women

Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy

Effects of Open-label Placebos on COVID-related Psychological Health

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer

Program to Overcome Pelvic Pain With Yoga

A Drug Interaction Study of Albiglutide and Digoxin

The HIIT Cognition Study

Family-based HIV Prevention for Adolescent Girls

mHealth for Young Adult Cancer Survivors

Immune Modulation During Palynziq® Treatment in Adults (IMPALA)

Supportive Intervention Programs Study

Development of the DRIVE Curriculum to Address Childhood Obesity Risk Factors

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

The Heart Health After Cardiac Treatment Study

Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

A Phase I/II Study of Intratumoral Injection of SD-101

Mobile Health App to Reduce Diabetes in Latina Women With Prior Gestational Diabetes II

The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine